Cyclin-Dependent Kinase 5 (Cdk5): A Potential Therapeutic Target for the Treatment of Neurodegenerative Diseases and Diabetes Mellitus

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|7|10|1070-1074

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.7, Iss.10, 2007-10, pp. : 1070-1074

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target

By  

Current Pharmaceutical Design, Vol. 18, Iss. 20, 2012-07 ,pp. : 2883-2890

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Cyclin-Dependent Kinases: Potential Drugs for the Treatment of Neurodegenerative Disorders?

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 2, 2005-01 ,pp. : 101-109

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents

By  

Current Medicinal Chemistry, Vol. 22, Iss. 2, 2014-12 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease

By  

Current Pharmaceutical Biotechnology, Vol. 4, Iss. 1, 2003-02 ,pp. : 21-37

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Use of Pharmacological Cyclin-Dependent Kinase Inhibitors as Anti-HIV Therapeutics

By  

Current Pharmaceutical Design, Vol. 12, Iss. 16, 2006-06 ,pp. : 1949-1961

Bentham Science Publishers

Access to resources Recommend Favorite